Literature DB >> 7534742

Late presentation of an alpha-fetoprotein secreting isolated large upper abdominal retroperitoneal Sertoli-Leydig cell tumor recurrence.

J H Farley1, R R Taylor, J R Bosscher.   

Abstract

The following case reports the surgical and adjuvant treatment of a solitary upper abdominal retroperitoneal recurrence of a poorly differentiated Sertoli-Leydig cell tumor (SLCT) which presented 4 years after the original diagnosis. The patient was treated with en bloc resection of the mass, which included her left kidney, adrenal gland, and distal pancreas. She received four courses of adjuvant chemotherapy and remains without evidence of malignancy. Both the primary and recurrent tumor secreted alpha-fetoprotein allowing serologic follow-up. The utility of serum alpha-fetoprotein in disease response to treatment and for surveillance of recurrence is also shown.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534742     DOI: 10.1006/gyno.1995.1055

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Endocrine pathology of the ovary : in tribute to Robert E Scully, MD.

Authors:  Esther Oliva; Robert H Young
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

Review 2.  Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.

Authors:  Mariana Horta; Teresa Margarida Cunha; Rita Canas Marques; Ana Félix
Journal:  J Radiol Case Rep       Date:  2014-11-30

3.  15-Year-Old Patient with an Unusual Alpha-Fetoprotein-Producing Sertoli-Leydig Cell Tumor of Ovary.

Authors:  Kaçar Serife; Stavros Karampelas; Nathalie Hottat; Christine Devalck; Katherina Vanden Houte
Journal:  Case Rep Obstet Gynecol       Date:  2022-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.